Other important findings showed that MAOB-related ROS production promotes a pro-oxidative status of endothelial dysfunction in coronary heart disease patients, and the MAOB inhibitor selegiline may be useful in restoring the endothelial response [13]. This evidence concerns the gene MAOB and endothelial dysfunction.